Johnson & Johnson (JNJ) - News Mentions

Sign up to add (JNJ) to your portfolio and access more historical data.

0 100%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Eli Lilly and Company
Eli Lilly and Company
LLY		 0 100%
Pfizer
Pfizer
PFE		 3 57.1%
Astrazeneca
Astrazeneca
AZN		 3 0%
AbbVie
AbbVie
ABBV		 1 50%
TherapeuticsMD
TherapeuticsMD
TXMD		 0 0%
Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
March 28
Johnson & Johnson Needs Time To Consolidate (Technical Analysis And Downgrade)
March 28
Cataract Surgery Devices Market Size and Shares Analysis 2025-2033 - A US$12.47 Billion Opportunity Led by Alcon, Johnson & Johnson, and Carl Zeiss Meditec
March 28
Johnson & Johnson MedTech to Highlight Latest Advancements in Heart Disease Treatment with Impella at ACC.25
March 27
2 Reasons to Like JNJ and 1 to Stay Skeptical
March 27
Johnson & Johnson (NYSE:JNJ) Presents Promising Nipocalimab Data At AAN Annual Meeting
March 27
Opportunities in the Global OTC Healthcare Sector 2024 - Forecasts to 2028 Featuring Haleon, Johnson & Johnson, Bayer, Sanofi-Aventis, and Reckitt Benckiser
March 27
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
March 26
Amazon - Johnson & Johnson All-Purpose Portable Compact First Aid Kit $16.52
March 26
Plaintiffs Double Down On Challenges To PBM Arrangements In Class Action Lawsuits Involving Johnson & Johnson And JPMorganChase
March 26
Jim Cramer Highlights Johnson & Johnson (JNJ) as a Rare Winner Amid Market Sell-Off
March 26
Johnson & Johnson MedTech introduces electrosurgical generator
March 26
Johnson & Johnson Reports Positive Data from Phase 3 Study of Lung Cancer Drug Candidate
March 26
Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock
March 25
India Urinary Tract Infection (UTI) Treatment Market Research 2025-2033 Featuring Analysis of Key Players - AstraZeneca, Bayer, GlaxoSmithKline, Johnson & Johnson, Novartis & More
March 25
Johnson & Johnson : MedTech Launches the DUALTO™ Energy System for Use Across Surgical Treatment Approaches
March 24

Month over Month

Est. daily news mentions.

Feb 2025 1
Jan 2025 2
Dec 2024 1
Nov 2024 0
Oct 2024 0

How often is Johnson & Johnson mentioned in the news?

Johnson & Johnson was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Johnson & Johnson performing compared to its industry peers?

Johnson & Johnson underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Johnson & Johnson in the last month?

Johnson & Johnson's was mentioned in fewer articles yesterday, compared to the same day last month.

Why is it important to track news mentions for Johnson & Johnson?

By monitoring mentions in the news for Johnson & Johnson, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Johnson & Johnson, ultimately improving their investment strategies.

Sign up and get more insights on Johnson & Johnson.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact